Latest news about Global Longlife Hospital & Research
Global Longlife Hospital & Research
11.29
+0.42(+3.86%)
Company Performance:
View Company Insights1D+3.86%
1M-4.56%
6M-49.39%
1Y-52.48%
5Y-91.66%
More news about Global Longlife Hospital & Research
30May 26
Global Longlife Hospital appoints internal auditor for FY 2026-2027
Global Longlife Hospital and Research Limited appointed M/s. J J Patel & Associates, Chartered Accountants, as its Internal Auditor for FY 2026-2027 following a Board meeting on May 30, 2026. The firm, holding FRN 133005W, will offer services including audit and assurance, GST matters, income tax, and financial consultancy.
07May 26
Global Longlife Hospital Reports ₹171.95L Net Loss for FY26; Board Approves Name Change
Global Longlife Hospital & Research Limited reported a net loss of ₹171.95 lakhs for the year ended March 31, 2026, reversing a net profit of ₹19.87 lakhs in FY25, with total income collapsing to ₹0.52 lakhs from ₹559.34 lakhs. The Board also approved a proposed name change to Kanzi Enterprise Limited, Asahi Enterprise Limited, or Siddhaa Enterprise Limited, along with an amendment to shift the company's main object clause from healthcare to trade and service, both subject to shareholder and regulatory approvals.
31Mar 26
Global Longlife Hospital Appoints Mr. Hiren Mandaliya as Additional Independent Director
Global Longlife Hospital & Research Limited has appointed Mr. Hiren Mandaliya (DIN: 11636452) as Additional Director in Independent capacity for five years effective March 31, 2026. The qualified Chartered Accountant brings strong expertise in accounting, taxation, and compliance management, with the appointment subject to shareholder approval and full regulatory compliance under SEBI regulations.
21Jan 26
Global Longlife Hospital Promoter Dhruv Jani Sells 3.67 Lakh Shares, Stake Reduces to 28.37%
Dhruv Sureshkumar Jani, promoter of Global Longlife Hospital & Research Limited, sold 3,67,000 equity shares (3.50% stake) through open market transactions between January 6-16, 2026. His shareholding decreased from 31.87% to 28.37% following the sale. The disclosure was made under SEBI Regulation 29(2) on January 20, 2026, with the company's shares listed on BSE under script code 543520.
29Dec 25
Global Longlife Hospital Promoter Sucheta Jani Completes Full Exit
Global Longlife Hospital promoter Sucheta Dhruvkumar Jani has completed her full exit by disposing of her remaining 2,53,000 equity shares on December 26, 2025, reducing her stake from 2.41% to zero. This final transaction, conducted through open market sales, marks the culmination of her systematic divestment strategy and complete exit from the promoter group of the healthcare company.
18Dec 25
Global Longlife Hospital Reports Additional Stake Sale by Dhruv Sureshkumar Jani
Global Longlife Hospital and Research Limited received another substantial shareholding disclosure from Dhruv Sureshkumar Jani for the sale of 50,000 equity shares under SEBI regulations. This follows his previous sale of 1,00,000 shares, bringing his total divestment to 1,50,000 shares and reducing his stake from 9.52% to 8.10% within a week through sequential open market transactions.
Industry Peers
Apollo Hospitals
Max Healthcare Institute
Fortis Healthcare
Aster DM Healthcare
Narayana Hrudayalaya
Global Health
Krishna Institute of Medical Sciences
Dr. Agarwal's Health Care
Rainbow Childrens Medicare
Park Medi World
8,655.00
(+0.73%)
1,149.90
(+2.36%)
950.40
(-0.46%)
765.70
(-0.44%)
1,902.90
(-2.75%)
1,304.70
(-0.59%)
805.45
(+1.27%)
474.15
(-2.17%)
1,405.50
(-2.02%)
289.70
(+1.47%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
